| Q44818812 | A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein |
| Q43625141 | A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity |
| Q38287365 | A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. |
| Q41254841 | A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes |
| Q33808561 | Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes |
| Q41610140 | CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. |
| Q35928180 | CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins |
| Q73362511 | Characterization of an HIV-1 p24gag epitope recognized by a CD8+ cytotoxic T-cell clone |
| Q70898280 | Computer simulations to predict the availability of peptides with known HLA class I motifs possibly generated by proteolysis of HIV-1 proteins in infected cells |
| Q40431645 | Cytotoxic T Lymphocytes and HIV-1-Related Neurologic Disorders |
| Q40393228 | Cytotoxic T Lymphocytes in Human Immunodeficiency Virus Infection: Responses to Structural Proteins |
| Q34194927 | Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina |
| Q45723753 | Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones |
| Q45743573 | Detection of simian immunodeficiency virus (SIV)-specific T-cell-mediated cytotoxicity in the peripheral blood from infected cynomolgus monkeys |
| Q24682788 | ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids |
| Q37363548 | Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. |
| Q34120763 | Immunodominant HIV-Specific CD8+T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers |
| Q36633526 | Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine |
| Q35869862 | Induction of anti-gp160 cytotoxic T cells cross-reacting with various V3 loop P18 peptides in human immunodeficiency virus type 1 envelope-immunized individuals. |
| Q36364647 | Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics |
| Q35237737 | Lipid Nanoparticles with Accessible Nickel as a Vaccine Delivery System for Single and Multiple His-tagged HIV Antigens |
| Q73198118 | Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines |
| Q40985184 | Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells |
| Q40612811 | MHC ligands and peptide motifs: first listing |
| Q34348269 | Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. |
| Q41447098 | Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities |
| Q39602888 | Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children |
| Q40801124 | Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance |
| Q41106437 | Potential deleterious effect of anti-viral cytotoxic lymphocyte through the CD95 (FAS/APO-1)-mediated pathway during chronic HIV infection |
| Q71646022 | Prediction of an HLA-B44 binding motif by the alignment of known epitopes and molecular modeling of the antigen binding cleft |
| Q45098418 | Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens |
| Q33835126 | Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons |
| Q33808201 | Quantitative analysis of the antiviral activity of CD8(+) T cells from human immunodeficiency virus-positive asymptomatic patients with different rates of CD4(+) T-cell decrease |
| Q40662326 | Quo vadis: perinatal AIDS issues--2004. |
| Q74233043 | Rational approaches to immune regulation |
| Q35176402 | Rational approaches to immune regulation. |
| Q33842771 | Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles |
| Q33819493 | Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques |
| Q45635794 | Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes |
| Q44439324 | The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design |
| Q39507159 | Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies |
| Q37412508 | Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen |